特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
925331

ペプチド合成市場 - 成長、動向、予測(2020~2025)

Peptide Synthesis Market - Growth, Trends, and Forecast (2020 - 2025)

出版日: | 発行: Mordor Intelligence LLP | ページ情報: 英文 120 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=106.14円
ペプチド合成市場 - 成長、動向、予測(2020~2025)
出版日: 2020年02月01日
発行: Mordor Intelligence LLP
ページ情報: 英文 120 Pages
納期: 2-3営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

調査対象のペプチド合成市場は、予測期間中に約12.5%のCAGRで成長すると予測されています。癌、糖尿病、肥満などの様々な生活習慣病の治療における用途の広い医薬品や消費者医療業界でのペプチドの採用が急上昇しています。例えば、2019年に発表された国際糖尿病連盟の報告書によると、約4億6300万人が糖尿病と共に生活しており、2型糖尿病は糖尿病の中で最も一般的なタイプであり、世界の糖尿病の約90%を占めています。このように、2型糖尿病の患者数の増加に伴い、ジペプチジルペプチダーゼ4(DPP-4)阻害剤、グルカゴン様ペプチド1(GLP-1)アナログなどのペプチド医薬品の需要が増加しており、これらの疾患に対する効率的な薬剤を合成することが予測期間中の市場を活性化させる可能性が高い状況です。

当レポートでは、ペプチド合成市場を調査し、市場概要、市場の成長要因および阻害要因の分析、技術別・製品別・エンドユーザー別・地域別の市場規模の推移と予測、競合情勢、主要企業のプロファイル、市場機会など、包括的な情報を提供しています。

目次

第1章 イントロダクション

  • 調査成果
  • 調査の前提条件
  • 調査範囲

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場力学

  • 市場概要
  • 市場成長要因
    • バイオ医薬品産業におけるゲノミクスおよびプロテオミクスの研究開発のための巨額の資金調達に伴う投資の増加
    • 強力なペプチド治療パイプラインと相まって、ペプチド合成装置における急速な技術進歩
  • 市場の抑制要因
    • 大規模なペプチド合成に関する問題と堅牢な配布ネットワークの欠如
    • ペプチド医薬品の適切な投与経路の開発における課題
  • ポーターのファイブフォース分析
    • 新規参入の脅威
    • バイヤー/消費者の交渉力
    • サプライヤーの交渉力
    • 代替製品の脅威
    • 競争の激化

第5章 市場細分化

  • 技術
    • 固相
    • 液相
    • ハイブリッド&組換え
  • 製品
    • 装置
    • 試薬と消耗品
    • その他
  • エンドユーザー
    • 製薬およびバイオテクノロジー企業
    • 受託開発および製造組織(CDMO)
    • 学術および調査機関
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • 中東・アフリカ地域
    • 南米

第6章 競合情勢

  • 企業プロファイル
    • AAPPTec
    • Anaspec Inc
    • Bachem Holding AG
    • Biotage AB
    • CEM Corporation
    • CSBio Company Inc
    • Gyros Protein Technologies AB
    • Merck KGaA
    • New England Peptide Inc
    • Thermo Fisher Scientific

第7章 市場機会および将来動向

目次
Product Code: 67871

The peptide synthesis market studied was anticipated to grow with a CAGR of nearly 12.5% during the forecast period. The major factors attributing to the growth of the market is a steep rise in the adoption of peptides in pharmaceutical and consumer healthcare industries owing to their wide range of applications in the treatment of various lifestyle disorders such as cancers, diabetes, and obesity. For instance, according to the International Diabetes Federation report published in 2019, around 463 million people are living with diabetes and Type 2 diabetes is the most common type of diabetes, accounting for around 90% of all diabetes globally. Thus, due to rise in the volume of patient pool with Type 2 diabetes, the demand for peptides is increasing owing to the available peptide medications such as dipeptidyl peptidase 4 (DPP-4) inhibitors, glucagon-like peptide 1 (GLP-1) analogs, etc to synthesize the efficient medication for these ailments is likely to fuel the market over the forecast period. Also, the increased research activities due to the rise in funding for R&D, and the advantages of advanced peptide synthesizers available in the can further boost the growth of the peptide synthesis market throughout the period.

Key Market Trends

The Solid Phase Synthesis by Technology Segment is Expected to Hold the Largest Market Share in the Peptide Synthesis Market

  • The solid-phase synthesis is expected to account for the largest revenue over the forecast period as it is the most common method of synthesis in chemicals and biopharmaceutical industries. This dominance is due to the wide range of advantages such as high-level automation, ease of operation in GMP manufacturing, easy purification in API process development with short production cycles, and ability to synthesize long peptides with a smaller amount of amino acids. Thus, owing to several distinct advantages over the liquid-phase procedure, the growth of the segment is expected to drive the market revenue over the forecast period.
  • Based on the end-user, pharmaceutical & biotechnology companies continue to dominate the market owing to the steep rise of peptide therapeutics industry because of their cost-effectiveness, enhanced efficiency with lower toxicity and ongoing drug development activities in life science research. On the other hand, the contract development and manufacturing organizations witness the highest CAGR throughout the forecast period owing to the advancements in the synthesizers, quality control, and reagents driving the segment and contribute to the growth of the global market.

North America Dominates the Market and Expected to do Same in the Forecast Period.

North America is expected to dominate the overall peptide synthesis market throughout the forecast period. The dominance is due to the growing prevalence of obesity with a rise in sedentary deskbound lifestyle and lack of proper diet along with physical activity resulting in various chronic diseases like diabetes in the United States necessitated the efficient treatment. For instance, according to the International Diabetes Federation in 2019, about 48 million adults in North America are living with diabetes and are expected to continue resulting in higher demand for peptide therapeutics driving the market in the region.

Furthermore, the increased availability of advanced healthcare infrastructure along with huge investments by the key players in this region to develop a new peptide synthesis technologies is also likely to fuel the market growth. Also, a favorable earlier approval of peptide drugs owing to the accelerated drug approval initiative by USFDA is also likely to fuel the market growth in this region across the forecast period contributing to its outstanding market share in the global peptide synthesis market.

Competitive Landscape

The peptide synthesis market is moderately competitive and consists of several major players. Some of the companies are expanding their market position by adopting various strategies such as acquisitions and mergers, research collaboration, while others are introducing new products to maintain their market share. For Instance, In May 2019, CEM Corporation launched Liberty PRO, the world's first-ever large-scale automated microwave peptide synthesizer. The system can synthesize 1 kg of crude peptide per batch utilizing reaction vessel, sizes up to 15 liters with unmatched purity, speed, and waste reduction fueling the market revenue share. Few of the major players currently dominating the industry in terms of revenue are AAPPTec, CSBio Company Inc, Biotage AB, Bachem Holding AG, and CEM Corporation.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Investments Along with Huge Funding for R&D of Genomics and Proteomics in Bio-pharmaceutical Industry
    • 4.2.2 Rapid Technological Advancements in Peptide synthesizers Coupled by Strong Peptide Therapeutics Pipeline
  • 4.3 Market Restraints
    • 4.3.1 Issues Pertaining to Large-scale Peptide Synthesis and Lack of Robust Distribution Network
    • 4.3.2 Challenges in Development of Proper Route of Administration of Peptide Drugs
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 Technology
    • 5.1.1 Solid-Phase
    • 5.1.2 Liquid-Phase
    • 5.1.3 Hybrid & Recombinant
  • 5.2 Product
    • 5.2.1 Equipment
    • 5.2.2 Reagents & Consumables
    • 5.2.3 Others
  • 5.3 End-User
    • 5.3.1 Pharmaceutical & Biotechnology Companies
    • 5.3.2 Contract Development & Manufacturing Organization (CDMO)
    • 5.3.3 Academic & Research Institutes
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United states
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 AAPPTec
    • 6.1.2 Anaspec Inc
    • 6.1.3 Bachem Holding AG
    • 6.1.4 Biotage AB
    • 6.1.5 CEM Corporation
    • 6.1.6 CSBio Company Inc
    • 6.1.7 Gyros Protein Technologies AB
    • 6.1.8 Merck KGaA
    • 6.1.9 New England Peptide Inc
    • 6.1.10 Thermo Fisher Scientific

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.